Clinical Trial: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07305779) titled 'A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women' on Dec. 12.

Brief Summary: The purpose of this study is to assess the effect of cytochrome P450 isoenzyme 2D6 (CYP2D6) inhibition by quinidine on the pharmacokinetic (PK) parameters of a single dose SEP-380135 in healthy adult participants.

Study Start Date: March 07

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: SEP-380135

Oral capsules.

DRUG: Quinidine Gluconate

Oral extended-release (ER) tablets.

Recruitment Status: COMPLETED

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Published by ...